Pharmacokinetic aspects of the clinically used proteasome inhibitor drugs and efforts toward nanoparticulate delivery systems is a research paper published in Journal of Pharmaceutical Investigation (2021). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Seoul National University
Grant: Creative-Pioneering Researchers Program
National Institutes of Health NCI
Grant: R01 CA232419
National Institutes of Health
Grant: 9R01CA232419-05
Chemotherapy delivery with nanoparticles for targeted induction of immunogenic cell death
Fields of Study
Sustainable Development Goals